[사진=게티이미지뱅크]
The second time after Pfizer, Moder or a new coronavirus infectious disease (Corona 19) vaccine has been approved, and interest in Mode or related stocks is drawing.
Moder or related stocks are Celltrion, kpx Life Science, Shinpoong Pharmaceutical, Woori Bio, and Yuhan Corporation.
As of 9:15 am on the 7th, Celltrion fell 0.14% (500 won) to 353,000 won, kpx Life Science fell 0.4% (50 won) to 12,000 won, and Shinpoong Pharmaceutical fell 0.41% (500 won). At 121,000 won, Woori Bio is trading at 5790 won, down 0.86% (50 won), while Yuhan Corporation is trading at 74,100 won down 3.26% (2500 won).
On the 6th (local time), the European Union (EU) executive committee approved the conditional sale of the modder or corovirus vaccine. This is the second approval after the Pfizer vaccine.
The EU Commission made an official approval decision on the morning of the morning just hours after the European Medicines Agency (EMA) recommended approval for conditional marketing of modders or vaccines, with the support of member states.
With this decision, each member state will be able to start vaccinating Moder or Corona 19. Supply is expected between the first and third quarters of this year.
“We will provide more COVID-19 vaccines for Europeans. With the second EU-approved Vaccine, Modena Vaccine, we will have an additional 160 million doses,” said Urzula Ponderrayen. Will be,” he explained.
Amid growing concerns about the current spread of Corona 19 and the spread of mutant viruses in the UK and South Africa, Pfizer vaccination was slow and criticism that the EU was not able to secure enough vaccines early, the Modena vaccine was approved.
The countries that have received approval for Moder or Corona 19 vaccines are the United States, Canada and Israel.
©’Five-language global economic newspaper’ Ajou Economy. Prohibition of unauthorized reproduction and redistribution